rs872346
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_020877.5(DNAH2):c.10169+3G>A variant causes a splice donor region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.344 in 1,613,956 control chromosomes in the GnomAD database, including 103,051 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.28 ( 6908 hom., cov: 31)
Exomes 𝑓: 0.35 ( 96143 hom. )
Consequence
DNAH2
NM_020877.5 splice_donor_region, intron
NM_020877.5 splice_donor_region, intron
Scores
2
Splicing: ADA: 0.00002793
2
Clinical Significance
Conservation
PhyloP100: -1.05
Genes affected
DNAH2 (HGNC:2948): (dynein axonemal heavy chain 2) Dyneins are microtubule-associated motor protein complexes composed of several heavy, light, and intermediate chains. The axonemal dyneins, found in cilia and flagella, are components of the outer and inner dynein arms attached to the peripheral microtubule doublets. DNAH2 is an axonemal inner arm dynein heavy chain (Chapelin et al., 1997 [PubMed 9256245]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 17-7817712-G-A is Benign according to our data. Variant chr17-7817712-G-A is described in ClinVar as [Benign]. Clinvar id is 402712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.387 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DNAH2 | NM_020877.5 | c.10169+3G>A | splice_donor_region_variant, intron_variant | ENST00000572933.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DNAH2 | ENST00000572933.6 | c.10169+3G>A | splice_donor_region_variant, intron_variant | 2 | NM_020877.5 | P1 | |||
DNAH2 | ENST00000389173.6 | c.10169+3G>A | splice_donor_region_variant, intron_variant | 2 | P1 | ||||
DNAH2 | ENST00000575105.1 | c.1016+3G>A | splice_donor_region_variant, intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.277 AC: 42068AN: 151970Hom.: 6902 Cov.: 31
GnomAD3 genomes
AF:
AC:
42068
AN:
151970
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.280 AC: 70247AN: 251192Hom.: 11693 AF XY: 0.286 AC XY: 38832AN XY: 135772
GnomAD3 exomes
AF:
AC:
70247
AN:
251192
Hom.:
AF XY:
AC XY:
38832
AN XY:
135772
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.351 AC: 512761AN: 1461866Hom.: 96143 Cov.: 86 AF XY: 0.347 AC XY: 252292AN XY: 727228
GnomAD4 exome
AF:
AC:
512761
AN:
1461866
Hom.:
Cov.:
86
AF XY:
AC XY:
252292
AN XY:
727228
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.277 AC: 42107AN: 152090Hom.: 6908 Cov.: 31 AF XY: 0.268 AC XY: 19939AN XY: 74346
GnomAD4 genome
AF:
AC:
42107
AN:
152090
Hom.:
Cov.:
31
AF XY:
AC XY:
19939
AN XY:
74346
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
430
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
DNAH2-related disorder Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 17, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at